Status Flu A + B Test Manufactured by Princeton Bio Meditech Corporation Monmouth Junction, NJ 08852 USA. The BioSign Flu A + B test is an in vitro rapid qualitative test that detects influenza type A and type B nucleoprotein antigens directly from nasal swab, nasopharyngeal swab and nasal pharyngeal aspirate/wash specimens obtained from patients with signs and symptoms of respiratory infection. It is intended to aid in the rapid differential diagnosis of influenza A and B viral infections. A negative test result is presumptive and it recommended that these results be confirmed by viral culture. Negative results do not preclude influenza virus infection and should not be used as the sole basis for treatment or other management decisions. The test is intended for professional and laboratory use.
Published September 12, 2012 · Recall initiated: March 9, 2012
Summary
FDA records medical device Class II recall Z-2308-2012, published September 12, 2012 and initiated March 9, 2012. Recalling firm: Princeton Biomeditech Corp; Status: Terminated; Reported quantity: 90 kits (22 tests per kit); Lot: 510 k K083746 Catalog Number 36022 Lot numbers 441H11 90 kits (22 tests per kit). Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.
Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.
What's the hazard
There have been reports of dual positive (Flu A + Flu B positive) results being encountered.
What to do
Voluntary: Firm initiated · Letter
Get an email when a new FDA recall like this is published
Free. We only write when there's a new recall that matches. Unsubscribe in one click.
Recall details
- Manufacturer
- Princeton Biomeditech Corp
- Distributor
- Nationwide Distribution-including the states of NJ, NY, and PA.
- Lot
- 510 k K083746 Catalog Number 36022 Lot numbers 441H11 90 kits (22 tests per kit)
- Risk classification
- Class II
- Area (FDA)
- device
- Country
- United States
Related recalls
- FDAOsom Ultra hCG Combo Test- IVD immunoassay for the qualitative detection of human chorionic gonadotropin (hCG)November 6, 2024
- FDAPoly stat Flu A & B Test Manufactured for Polymedco 510 Furnace Dock Road Cortlandt Manor, NY 10567 TelSeptember 12, 2012
- FDAOrasure QuickFlu Rapid A+B Test Manufactured for OraSure Technologies, Inc Bethlehem, PA 18015 USA. TheSeptember 12, 2012
- FDAZilver 518 Vascular Self Expanding Stent The Zilver Vascular Stent is intended for use as an adjunct toSeptember 12, 2012
- FDAOPTETRAK LOGIC TIBIAL INSERT POSTERIOR STABILIZED***Match Component Colors 6 YELLOW, 11mm, Use with LOGICSeptember 12, 2012
- FDAsyngo(R) Lab Data Manager and syngo(R) Lab Process Manager, all versions. This device is classified as a dataSeptember 12, 2012
Questions about this recall
Was Status Flu A + B Test Manufactured by Princeton Bio Meditech Corporation Monmouth Junction, NJ 08852 USA. The BioSign Flu A + B test is an in vitro rapid qualitative test that detects influenza type A and type B nucleoprotein antigens directly from nasal swab, nasopharyngeal swab and nasal pharyngeal aspirate/wash specimens obtained from patients with signs and symptoms of respiratory infection. It is intended to aid in the rapid differential diagnosis of influenza A and B viral infections. A negative test result is presumptive and it recommended that these results be confirmed by viral culture. Negative results do not preclude influenza virus infection and should not be used as the sole basis for treatment or other management decisions. The test is intended for professional and laboratory use. recalled?
Yes. FDA published recall Z-2308-2012 on September 12, 2012. Reported hazard: There have been reports of dual positive (Flu A + Flu B positive) results being encountered.
What should I do if I have this product?
Voluntary: Firm initiated · Letter